Newron Pharmaceuticals S.p.A.
NWPHF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | $21 | -$16 | -$17 | -$15 |
| Dep. & Amort. | $0 | $0 | $0 | $0 |
| Deferred Tax | $0 | $0 | $0 | -$3 |
| Stock-Based Comp. | $0 | $0 | $0 | $1 |
| Change in WC | -$38 | $2 | -$1 | $2 |
| Other Non-Cash | -$2 | $4 | $6 | $3 |
| Operating Cash Flow | -$18 | -$10 | -$11 | -$11 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | -$0 | -$0 | -$0 |
| Net Acquisitions | $0 | -$3 | $0 | -$8 |
| Inv. Purchases | -$2 | -$1 | -$3 | -$2 |
| Inv. Sales/Matur. | $5 | $4 | $3 | $10 |
| Other Inv. Act. | $0 | $3 | -$0 | $8 |
| Investing Cash Flow | $3 | $3 | -$0 | $8 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $15 |
| Stock Issued | $15 | $0 | $0 | $0 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$0 | -$0 | -$0 | -$0 |
| Financing Cash Flow | $15 | -$0 | -$0 | $15 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $1 | -$7 | -$12 | $12 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $6 | $13 | $25 | $13 |
| End Cash | $7 | $6 | $13 | $25 |
| Free Cash Flow | -$18 | -$10 | -$11 | -$11 |